Protocols
1 protocol(s) meet the specified criteria
Drug: Polatuzumab Vedotin
Protocol No.TitleStatus
GO39942A Phase III, Multicenter, Randomized,Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with Diffuse Large B-Cell LymphomaOpen